We asked 5 nephrologists how they decide when to initiate dialysis for a patient with borderline indications. #nephrology #nephsky #dialysis #kidneydisease 🔗 www.docwirenews.com/post/5-nephr...

In this interview, Dr. Howard Trachtman discusses targeted therapies for FSGS, including BI 764198, a TRPC6 inhibitor that was the subject of a recent study published by The Lancet. #kidneydisease #FSGS #nephrology #nephsky buff.ly/CvQ7u8J

🎺It's here! ➡️ www.docwirenews.com/journal/marc... Check out our latest issue online, featuring universal CKD screening, patient collection strategies, the role of neph NPs, and much more. #nephrology #nephsky

Dr. Sumair Akhtar offers a clinician’s perspective on why cognitive decline in CKD is multifactorial, difficult to detect, and essential to confront head-on. #kidneydisease #ckd #cognitivedecline #nephrology #nephsky www.docwirenews.com/post/the-con...

❓️ ICYMI: We asked 5 nephrologists, "What recent research has most changed your approach to managing glomerulonephritis?" #nephrology #nephsky #glomerulonephritis #kidney @sophia-kidney.bsky.social @brycebarr.bsky.social www.docwirenews.com/post/5-nephr...

We spoke with @hswapnil.medsky.social, editor of the newly launched Kidney International Case Reports, about the value of case reports in nephrology. #nephrology #casereports www.docwirenews.com/post/reconsi...

In the final segment of their conversation, @annagaddy.bsky.social chats with Miriam Godwin and Lauren Drew of @kidney.org about NKF’s multiprong approach to advocacy and ways for healthcare professionals to get involved. #nephrology #healthpolicy www.docwirenews.com/post/public-...

Study findings suggest food assistance has a role in mitigating chronic kidney disease progression among children. #nephsky #pediatricnephrology #kidneydisease #CKD #foodinsecurity #socialdeterminantsofhealth docwirenews.com/post/impact-...

In part 2 of their conversation, @annagaddy.bsky.social chats with Miriam Godwin and Lauren Drew of @kidney.org about aligning policy, regulation, and quality metrics to make kidney care earlier, better, and more patient centered. #nephrology #healthpolicy www.docwirenews.com/post/public-...

A retrospective cohort analysis highlights an association between depression and chronic kidney disease progression. #nephrology #nephsky #kidneydisease #ckd #depression docwirenews.com/post/higher-...

Although it is less common in nephrology than in some other specialties, there is a compelling case for palliative care in advanced kidney disease. #nephrology #nephsky #kidneydisease #palliativecare www.docwirenews.com/post/a-diffe...

In part 1 of their conversation, @annagaddy.bsky.social chats with Miriam Godwin and Lauren Drew of @kidney.org about the importance of public health policy for kidney care and the impact of the advocacy of healthcare professionals. #nephrology #healthpolicy www.docwirenews.com/post/public-...

Dr. Jami Brown, a nephrology nurse and National Secretary of ANNA, shares strategies to recruit, support, and retain nephrology nurses. #nephrology #nephsky #nursing www.docwirenews.com/post/strengt...

Watch our interview with Kevin Fowler discussing truly patient-centered neph care. #nephrology #nephsky #kidneycare #patientactivation @gratefull080504.bsky.social www.docwirenews.com/post/centeri...

The annual Medicare Cost Report deadline will arrive quickly. Are you ready? #medicare #nephrology #reimbursement #costreporting #healthcarecompliance www.docwirenews.com/post/prepari...

MMWR reported the death of a #kidneytransplant recipient from #rabies acquired from an organ donor. The case offers lessons on the importance of rapid detection, structured communication, and coordinated response. #nephrology #nephsky #organdonation

Recent kidney news includes an update on xenotransplant recipient Tim Andrews and more. #nephrology #nephsky www.docwirenews.com/post/kidney-...

Extended follow-up of the SAILOR trial shows steroid avoidance with low-dose tacrolimus is safe and effective up to 7 years after kidney transplant. #nephrology #nephsky #KidneyTransplant www.docwirenews.com/post/low-dos...

🥗What's in the new US dietary guidelines, and how do the changes support or challenge renal nutrition? Dietitian Kate Zalewski chimes in. @katmarzal.bsky.social #nephrology #nephsky #kidneydisease #renalnutrition www.docwirenews.com/post/new-us-...

HOT OFF THE PRESSES! Get a sneak peek at the latest print issue, featuring palliative care for kidney disease, strengthening neph nursing, innovation in kidney transplantation, prepping for Medicare Cost Reports, and more. #nephrology #nephsky www.docwirenews.com/journal/janu...

In the final part of their conversation with @annagaddy.bsky.social, @garysinger.bsky.social and @robertblaser.bsky.social of the Renal Physicians Association discuss the policy issues nephrologists should watch. #nephrology #nephsky #publicpolicy www.docwirenews.com/post/public-...

Is IVIG finally something that works in chronic active AMR? A multicenter RCT suggests better graft stability vs standard care alone. #AMR #graftrejection #kidneytransplant #transplantation #nephrology #nephsky www.docwirenews.com/post/ivig-li...

In part 2 of their conversation, @garysinger.bsky.social and @robertblaser.bsky.social of the Renal Physicians Association discuss #publicpolicy priorities for #nephrology in 2026 with @annagaddy.bsky.social. #nephsky www.docwirenews.com/post/public-...

Our own @annagaddy.bsky.social sat down with @garysinger.bsky.social and @robertblaser.bsky.social of the Renal Physicians Association to talk #publicpolicy and #nephrology. Find out why policy should matter to nephrologists in the first part of their discussion. #nephsky ➡️ tinyurl.com/567xczxc

Should we be using MRAs post–kidney transplant? A new meta-analysis says: ❌ No measurable benefit ⬆️ Higher hyperkalemia risk #nephrology #kidneytransplant #transplantation #hyperkalemia #nephsky docwirenews.com/post/steroid...

💡 Have an idea for a topic Nephrology Times should cover? 📝 Want to contribute? 📣 We want to hear from you! Leave us a comment or email charlotte[dot]robinson[at]formedics[dot]com

🗞️ CATCH UP with kidney news, including an FDA delay for sparsentan in #FSGS, a new #CKD guideline from two government agencies, and more. #nephsky #nephrology #kidneytransplant #kidneydisease www.docwirenews.com/post/kidney-...

💥 The new update to KDIGO's #anemia in #CKD guideline (its first since 2012) puts an emphasis on individualized care and emerging therapies. 💊 #kidneydisease #nephrology #nephsky www.docwirenews.com/post/anemia-...

Kidney transplant recipients receiving MDR-101 achieved immune tolerance, stopping immunosuppression for >2 years with no graft loss or graft-vs-host disease. #nephrology #nephsky #KidneyTransplant www.docwirenews.com/post/cell-th...

Nephrologists with opinions (so, all of you): We’re recruiting for our recurring feature, “5 Nephrologists, 1 Question.” Short answers (~100 words), real-world concerns, no lectures. 📧 Email: charlotte[dot]robinson[at]formedics[dot]com #nephrology #nephsky

In a trial in Thailand, no significant differences in health-related quality of life were found between children with stage 5 CKD receiving automated vs continuous ambulatory peritoneal #dialysis. #nephrology #nephsky #PediatricNephrology www.docwirenews.com/post/automat...

In the ALCHEMIST trial, spironolactone did not reduce major #cardiovascular events in people with kidney failure receiving chronic #hemodialysis. #nephrology #nephsky www.docwirenews.com/post/study-d...

The SAFE-D pilot trial shows recruitment and adherence are feasible for anticoagulation strategies in people with AF receiving #dialysis. #nephrology #nephsky #AtrialFibrillation www.docwirenews.com/post/pilot-t...

Hot takes, but make them #nephrology. 🔥🩺 Looking for clinicians to contribute to a recurring feature: “5 Nephrologists, 1 Question.” Short answers. Rotating topics. More fun than polishing a manuscript. 📧 Email: charlotte[dot]robinson[at]formedics[dot]com #nephsky

In adults with provoked VTE and enduring risk factors, 12 months of low-dose apixaban reduced recurrent clots with a low risk of major bleeding. #nephrology #nephsky #dialysis www.docwirenews.com/post/apixaba...

In the RENIS cohort, higher physical activity was linked to slower GFR decline and lower risk of accelerated kidney function loss over 11 years. #nephrology #nephsky www.docwirenews.com/post/physica...

In a post hoc ADVOCATE analysis, avacopan improved kidney recovery, reduced relapse, and lowered glucocorticoid toxicity in people with GPA or MPA and kidney involvement. #nephrology #nephsky #granulomatosis #polyangiitis www.docwirenews.com/post/avacopa...

The phase 3 APPEAR-C3G study showed iptacopan significantly reduced proteinuria at 6 months in people with C3 glomerulopathy. #nephrology #nephsky #C3G www.docwirenews.com/post/iptacop...

In a national cohort from the Netherlands, 37% of children treated for cancer developed #AKI, which strongly predicted #CKD at 1 year. #nephrology #nephsky www.docwirenews.com/post/kidney-...

Have 10 minutes and an opinion about kidneys? 🫘 We’re seeking contributors for “5 Nephrologists, 1 Question.” One #nephrology question. Short answer. Email: charlotte[dot]robinson[at]formedics[dot]com #nephsky

We are delighted to announce that Anna Gaddy, MD, has joined the Nephrology Times editorial board. www.docwirenews.com/post/nephrol...

New Year’s resolutions tend to fail by February. Reading Nephrology Times is one you can actually keep. Happy New Year. 🥂 nephtimes.com

Research suggests a validated risk-prediction tool can estimate an individual patient’s likelihood of survival with conservative care compared with dialysis in advanced chronic kidney disease. Read more on Nephrology Times. 👉 www.docwirenews.com/post/predict... #nephrology #ckd #kidneydisease

Pediatric results from DUPLEX show sparsentan is well tolerated and achieves superior, sustained proteinuria reduction versus the maximum IRB dose in FSGS. #KidneyWk #nephsky #Nephrology #FSGS #Pediatrics www.docwirenews.com/post/sparsen...

Do you have strong opinions about #nephrology and ~10 minutes? 👀 Participate in our recurring feature: “5 Nephrologists, 1 Question.” Short (~100 words), practical, clinician-focused answers to a neph question. 📧 Email: charlotte[dot]robinson[at]formedics[dot]com #nephsky

What role do CD38+ immune cells play in AMR and glomerular disease? Georg Böhmig, MD, shares insights from #KidneyWk and what’s next for CD38-targeted therapies. #nephrology #nephsky #kidneytransplantation #kidneydisease www.docwirenews.com/post/targeti...

🩺 Nephrologists: Speak up! Want to share your insight in a future “5 Nephrologists, 1 Question” feature? Send an email to charlotte[dot]robinson[at]formedics[dot]com.

ICYMI: RUBY-3 demonstrates that targeting BAFF and APRIL with povetacicept can drive proteinuria reduction and immunologic remission in IgAN and pMN. #KidneyWk #nephsky #Nephrology #ClinicalTrials www.docwirenews.com/post/povetac...

SPRINT data show intensive BP control favors most CKD patients, with greatest net benefit in those with lower eGFR. #KidneyWk #nephrology #CKD #hypertension #nephsky www.docwirenews.com/post/intensi...

🩺 Nephrologists: Speak up! Want to share your insight in a future “5 Nephrologists, 1 Question” feature? Send an email to charlotte[dot]robinson[at]formedics[dot]com.